Articles tagged with Antibiotic Resistance
A new study found that hospital-affiliated emergency physicians prescribed antibiotics to patients with acute respiratory infections nearly twice as often as contractor-supplied physicians. This disparity highlights the need for improved antibiotic stewardship in telemedicine settings.
A new study found that fungal infections result in significant healthcare spending, with direct costs of $6.7 billion and secondary infections contributing to a total of $37.7 billion in U.S. national health care expenses. Fungal infections doubled hospital costs, patient stays, and mortality risk.
Researchers developed an antibiotic prescribing algorithm using genomic sequencing and machine learning analysis, reducing the emergence of antibiotic resistance in bacterial infections. The algorithm matches an antibiotic to a patient's past infection history and microbiome to minimize resistance spread.
Researchers have discovered the structure of C.difficile's protective armor, a chain-mail like layer that prevents molecules from entering the cell. This discovery opens the possibility of designing specific drugs to target the armor and kill the cell.
Researchers at the University of Texas at Austin found a new approach to impairing antibiotic resistance in deadly bacteria by inhibiting the protein DsbA. This method could potentially restore the effectiveness of existing antibiotics, addressing a global health crisis responsible for millions of deaths annually.
Researchers found that antibiotics prescribed to newborns decrease healthy Bifidobacterium species and promote antimicrobial resistance. The study suggests that clinicians should use antibiotics with minimal harm to the baby's microbiome.
Researchers discovered how a single mutation in an enzyme enables bacteria to evade antibiotics by using mirrored structures. This finding has implications for developing more resilient inhibitors and proactive drug designs.
A Swedish registry study found no increase in endocarditis cases among high-risk individuals since the removal of prophylactic antibiotics in dentistry. The study monitored over 76,000 high-risk individuals and 396,000 low-risk individuals from 2008 to 2018.
A recent global study found that more than a quarter of the world's rivers had pharmaceutical concentrations at potentially toxic levels. The study, which included data from over 258 rivers across seven continents, also revealed concurrent contamination by multiple classes of pharmaceuticals.
SMART researchers identified a novel phage lysin, Abp013, with promising antimicrobial ability against Acinetobacter baumannii and Klebsiella pneumoniae. The study demonstrated Abp013's ability to effectively target complex bacterial environments and could advance treatment methods for multidrug-resistant Gram-negative pathogens.
Researchers discovered a signaling mechanism allowing intracellular bacteria like Salmonella to outmaneuver host defenses. By triggering macrophage death and activating the complement system, these bacteria can safely deliver themselves into another macrophage. This 'hack' enables them to persist within infected hosts.
A mathematical modeling study predicts that routine immunization with TCV could avert 46-74% of all typhoid fever cases in 73 countries. Vaccination is also expected to reduce the relative prevalence of antimicrobial-resistant typhoid by 16%, preventing millions of cases and deaths.
Researchers have imaged an enzyme involved in carbapenem biosynthesis, shedding light on the process of creating a potent side chain that makes these antibiotics effective against antibiotic-resistant bacteria. The discovery could lead to improved antibiotics and new strategies for combating bacterial resistance.
A new genomics study has helped guide the development of vaccines against Shigella, a leading cause of severe diarrhoea in children. The research revealed the extent of genomic diversity among Shigella species, highlighting challenges to current vaccine approaches.
Scientists discovered that surviving bacteria share a common feature: they accumulate acid in their cells, shutting down protein synthesis. This leads to increased survival and can be exploited to develop new antimicrobial treatments.
Decision-making tools, including a double-sided document and video training, were ineffective in reducing antibiotic prescription rates for acute respiratory infections. Despite this, general practitioners' knowledge of relevant evidence increased significantly after the intervention.
Researchers at TTUHSC developed novel hydrophilic nanoparticles that target bacterial membranes, killing pathogens while sparing mammalian cells. The nanoantibiotics' size-dependent activity reveals a new blueprint for developing non-toxic and environmentally friendly antibiotics.
A new report estimates that antibiotic-resistant bacterial infections caused over 1.27 million deaths worldwide in 2019, with the greatest impact on lower respiratory and bloodstream infections. The study highlights the urgent need to combat antimicrobial resistance and provides immediate actions for policymakers to save lives.
Researchers developed a mathematical model that can predict resistance outcomes for various drug pairs. The model, called JDFE, characterizes mutations available to bacteria and allows for classification of drug pairs into those that facilitate or hinder multi-drug resistance.
Rice University researchers developed a microfluidic platform to analyze how infectious bacteria evolve resistance to antibiotics. The platform allows for controlled environments and fine-tuning of conditions, revealing previously unknown pathways to resistance.
A new EU-funded project, MUSIC, will investigate how bacterial defences influence the spread of mobile genetic elements (MGEs) between bacteria. MGEs can change key traits of bacteria, including antibiotic resistance and virulence.
Researchers have pinpointed a gene in E. coli ST131 that makes it highly resistant to antibiotics, leading to new treatment strategies and improved tracking of emerging resistance. The study aims to create better treatments to stop deadly E. coli infections.
Researchers at Sanford Burnham Prebys have received a $3.6 million grant to study antibiotic resistance, employing an innovative approach known as the 'evolution machine.' This project aims to shed new light on how bacteria develop resistance and inform more precise antibiotic prescribing practices.
A study published in Nature found that a type of MRSA called mecC-MRSA originated in hedgehogs over 200 years ago, long before the clinical use of antibiotics. The researchers believe that the bacteria evolved as an adaptation to living on the skin of hedgehogs with a fungus that produces its own antibiotics.
Researchers at Rockefeller University have discovered a novel compound called macolacin that is highly potent against multidrug-resistant bacteria, including those resistant to colistin. The compound was discovered using an evolutionary approach to antibiotic discovery and has shown promising results in lab experiments.
A new species of antibiotic-resistant bacteria, Enterococcus innesii, has been discovered by researchers at the John Innes Centre. The strain is resistant to vancomycin and may cause hospital-acquired infections.
New research combines antibiotics and phage therapy to cure infections more effectively and reduce antibiotic use. The study found that bacteriostatic antibiotics trigger CRISPR-Cas adaptive immunity in bacteria, increasing the chances of treatment efficacy.
Scientists have discovered a new potential treatment to reverse antibiotic resistance in bacteria causing sepsis, pneumonia, and urinary tract infections. The indole carboxylates class of enzyme blockers can stop MBL resistance enzymes from working, allowing antibiotics like carbapenems to effectively target bacteria.
A new study reveals widespread prescribing of clarithromycin-based regimens for H. pylori infection, defying increasing resistance and suboptimal eradication rates. Talicia, a rifabutin-based therapy, offers an alternative with higher eradication rates and fewer concerns over resistance.
Scientists have developed an enzyme that degrades the capsule surrounding the bacterium that causes anthrax, reducing virulence and protecting mice from infection. The treatment, known as PEG-CapD-CPS334C, is a promising avenue for treating multidrug-resistant anthrax and other bacterial infections.
Researchers discovered that blood stem cells use high-energy fatty acids from the body's fat stores to power up their response to infection. This finding could lead to new approaches in treating bacterial infections, particularly in vulnerable and older individuals.
Researchers at USC developed a new peptide that stimulates the host's immune response to fight bacterial infections, offering an alternative to antibiotics. The peptide, MTD12813, is highly effective in clearing infections and modulates inflammation, reducing the risk of complications.
A new study led by Rice University engineers finds that microplastic pollution contributes to the spread of antibiotic-resistant genes. The researchers discovered that aging polystyrene breaks down into microplastics with high surface areas, trapping microbes and leaching chemicals that enhance gene transfer.
A new white paper shares practical strategies to inform stewardship efforts and ensure appropriate use of antibiotics, citing the public health crisis of antibiotic resistance leading to 23,000 preventable deaths each year. Implementation science principles can bridge the evidence-practice gap.
Researchers from the University of Manchester have discovered a new way to manipulate key assembly line enzymes in bacteria using CRISPR-cas9 gene editing. This approach could lead to the production of improved antibiotics with potentially improved properties, addressing the growing threat of antimicrobial resistance.
Researchers from Trinity College Dublin investigate the epidemiology and population biology of Enteroccocus faecium, a high-priority pathogen. They found that Irish isolates have evolved independently and are diverse, with a unique genetic transposon element encoding vancomycin resistance.
A recent study found that antibiotic resistance rates for Helicobacter pylori are decreasing in European countries. The use of three antibiotics over 10-14 days resulted in success rates of over 90%. The researchers hope to reduce antibiotic consumption to prevent further resistance.
Researchers have found that ultrashort-pulse lasers can inactivate antibiotic-resistant bacteria and bacterial spores, reducing their numbers by over 1,000 times. The technology has the potential to be used to sterilize wounds and disinfect blood products, and may also be used to treat bloodstream infections.
A study led by New York University researchers found that the FDA-approved hepatitis C treatment telaprevir can increase bacterial sensitivity to antibiotics and reduce antibiotic resistance. The antiviral blocks the function of essential proteins in bacteria, revealing an opportunity to repurpose the drug to use alongside antibiotics.
The European Union and European Economic Area saw a significant decline in antibiotic consumption in 2020, with a 18% decrease compared to 2019. This decline was largely attributed to the COVID-19 pandemic, which led to reduced primary care consultations for mild infections.
Researchers at the University of Texas at Dallas have developed a vaccine method against recurrent urinary tract infections (UTIs) using metal-organic frameworks. The new approach produces substantially enhanced antibody production and significantly higher survival rates in mice compared to standard vaccine preparation methods.
Researchers have identified compounds that interfere with fungal enzymes required for fatty acid synthesis, potentially overcoming resistance to current treatments. These compounds show promise as antifungal agents, effective even against drug-resistant strains of fungi.
A study by Anglia Ruskin University has identified potentially dangerous Pseudomonas bacteria in 21% of wild bird faeces collected from locations near the River Cam. The bacteria, which can be passed on to humans through cross-contamination, were resistant to multiple antibiotics.
Researchers at Karolinska Institutet have discovered a new group of small antibacterial compounds that inhibit the formation of bacterial cell walls, showing promise against antibiotic-resistant strains. The molecules work by binding to lipid II, a crucial molecule for bacterial cell wall construction.
A rapid same-day test has been developed to identify secondary infections in COVID-19 patients on intensive care, allowing for targeted antibiotic treatment and reduced risk of antimicrobial resistance. The test uses nanopore sequencing technology to analyze bacterial and fungal pathogens present in patient samples.
Research identifies way of using nanoparticles to target and disrupt bacterial cells, making them more susceptible to standard antibiotic treatments. Laboratory studies show a strong effect in killing a range of bacteria, including some linked to hospital-acquired infections.
Scientists used computational strategies to evaluate antibiotic candidates, identifying a promising new variant that is up to 56 times more active than existing antibiotics. This approach enables faster and more affordable development of new antibiotics, helping to combat resistance.
A new study found that most pregnant women with a penicillin allergy label are not allergic, but rather have Group B Strep or need antibiotics for labor. Testing for penicillin allergy can help reduce antibiotic exposure and ensure safer treatment options.
A new technique measures bacterial metabolic activity with an electric probe to identify antibiotic resistance in less than 90 minutes. This rapid method enables doctors to quickly determine which antibiotics will or won't work for a patient's infection, improving treatment decisions and potentially saving lives.
The need for new antibiotics is critical due to rising antibiotic resistance, which kills over 35,000 people annually in the US. Research by Harvard Medical School aims to develop better antibiotics by targeting essential bacterial proteins.
Researchers have made a giant leap in fighting antibiotic resistance by using supercomputers to redesign existing antibiotics. The new approach shows that the redesigned antibiotic is up to 56 times more active than two existing antibiotics on the World Health Organisation's list, and potentially effective against three top-ranked bact...
Researchers at Karolinska Institutet discovered that interleukin-26 plays a critical role in bacterial pneumonia by directly killing bacteria and modulating the immune system. This finding positions IL-26 as a new potential target for biological treatment of pneumonia, an increasing global health threat.
A study published in The Lancet Infectious Diseases found that temocillin was effective in treating febrile urinary tract infections with fewer resistant bacteria. Temocillin acts specifically against E. coli and other intestinal bacteria, reducing the risk of treatment failure.
A new study reveals that iboxamycin effectively fights both gram-negative and gram-positive drug-resistant bacteria in mouse models. The researchers discovered the molecular mechanism that allows this drug to overcome resistance, which is important for developing new antibiotics.
A study found that infant formula is associated with a 70% higher occurrence of antibiotic resistance genes in newborns. Breastfeeding, on the other hand, reduces the proliferation of opportunistic pathogens, potentially lessening the risk of difficult infections.
Researchers have recorded the sharpest images of living bacteria, revealing a complex architecture that makes them harder to kill by antibiotics. The study found that bacteria with protective outer layers may have stronger and weaker spots on their surface.
Researchers revealed that β-lactam antibiotics like penicillin kill MRSA by forming small holes in the cell wall, which gradually enlarge and lead to bacterial death. This discovery provides new avenues for treatment developments against antibiotic-resistant superbugs.
Researchers at Cornell University used machine learning to predict the spread of antibiotic resistance genes among bacteria, identifying potential networks of exchange and driving factors. The approach could help control the spread of antibiotic resistance and develop new targets for novel antibiotics.
Researchers at the University of Bonn discovered a novel resistance mechanism in Staphylococcus aureus, which protects the bacteria from vancomycin. By binding vancomycin to its cell wall, the strain prevents the antibiotic from reaching the membrane and killing the bacteria.
Researchers have developed new qPCR assays to quantify the transmission of antimicrobial resistance (AMR) using water and wastewater samples. These methods provide a more exact way to determine AMR by measuring DNA in wastewater samples.